Click here to download the August 2020 edition.
ABPI Restores Novo Nordisk’s Membership
The pharmaceutical company had previously been subjected to a 2-year suspension.
The Challenges of Market Access in Europe that Pharma Companies Face: Q&A with Mike Ryan
Pharma companies face unique challenges with market access in this region.
Eli Lilly Announces Four New Domestic Production Sites
Three of the new sites will focus primarily on producing ingredients for domestic usage.
Navigating the EU’s Joint Clinical Assessment
Pathways to success for this key component of Europe’s new HTA regulation, where thinking beyond the purely technical will be critical.
Navigating Cross-Border Pharma Deals: Key Trends and Lessons Out of China
The importance of a strategic approach and proper due diligence in unlocking the full potential of these arrangements.
Exploring Biopharma's Dealmaking Terrain, Roadmap in China
A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.
